University of Chinese Academy of Sciences , Beijing 100049 , China.
UCB Pharma , Slough , SL1 14EN Berkshire , U.K.
ACS Appl Mater Interfaces. 2018 May 9;10(18):15442-15448. doi: 10.1021/acsami.8b02626. Epub 2018 Apr 25.
The advent of DNA technology has demonstrated great potential in a wide range of applications, especially in the field of biology and biomedicine. However, current understanding of the toxicological effects and cellular responses of DNA nanostructures remains to be improved. Here, we chose tetrahedral DNA nanostructures (TDNs), a type of nanocarriers for delivering molecular drugs, as a model for systematic live-cell analysis of the biocompatibility of TDNs to normal bronchial epithelial cells, carcinoma cells, and macrophage. We found that the interaction behaviors of TDNs in different cell lines were very different, whereas after internalization, most of the TDNs in diverse cell lines were positioned to lysosomes. By a systematic assessment of cell responses after TDN exposure to various cells, we demonstrate that internalized TDNs have good innate biocompatibility. Interestingly, we found that TDN-bearing cells would not affect the cell cycle progression and accompany cell division and that TDNs were separated equally into two daughter cells. This study improves our understanding of the interaction of DNA nanostructures with living systems and their biocompatibility, which will be helpful for further designing DNA nanostructures for biomedical applications.
DNA 技术的出现展示了在广泛应用领域中的巨大潜力,特别是在生物学和生物医学领域。然而,目前对 DNA 纳米结构的毒理学效应和细胞反应的理解仍有待提高。在这里,我们选择四面体 DNA 纳米结构(TDN)作为一种用于递分子药物的纳米载体,对 TDN 对正常支气管上皮细胞、癌细胞和巨噬细胞的生物相容性进行了系统的活细胞分析。我们发现,TDN 在不同细胞系中的相互作用行为非常不同,而在内化后,大多数 TDN 在不同的细胞系中都被定位到溶酶体中。通过对 TDN 暴露于各种细胞后的细胞反应进行系统评估,我们证明了内化的 TDN 具有良好的固有生物相容性。有趣的是,我们发现携带 TDN 的细胞不会影响细胞周期进程,并伴随细胞分裂,而且 TDN 被平均分配到两个子细胞中。这项研究提高了我们对 DNA 纳米结构与生命系统相互作用及其生物相容性的理解,这将有助于进一步设计用于生物医学应用的 DNA 纳米结构。